|
|
Article: GANGAGEN DEVELOPING PIPELINE FROM BACTERIOPHAGE RESEARCH.
- Article from:
- BIOWORLD Today
- Article date:
- March 1, 2004
- Author:
CopyrightCOPYRIGHT 2004 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: Karen Young, Staff Writer
When Ernest Hankin made the first discovery of the activity of bacteriophages in India in 1896, he had no idea that more than 100 years later, a company would be based on the potential use of those "bacteria eaters" to cure contemporary illness.
GangaGen Inc. is looking to bacteriophages and that century-old bacteriophage discovery for its own science. But the company says bacteriophages took a back seat to antibiotics once antibiotics were introduced.
GangaGen, whose executive office is in San Francisco but has research and development facilities in Bangalore, as well as a life sciences subsidiary in Ottawa, ...